PDS Biotechnology Corp. (NASDAQ:PDSB)

About the company

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

20

$NoneM

Total Revenue

20

Employees

$13.30M

Market Capitalization

-0.52

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 383533.80 82729.00 6.16 22.35 20.75
Merck & Co., Inc. MRK 199942.72 48081.00 7.51 19.73 21.10
Pfizer Inc. PFE 190383.75 50660.00 2.88 12.05 31.17
Eli Lilly & Co. LLY 155261.34 23087.00 52.69 27.37 23.97
AbbVie, Inc. ABBV 144918.98 34057.00 -23.20 17.28 24.65
Bristol Myers Squibb Co. BMY 111198.52 31006.00 2.70 94.54 3.08
Repligen Corp. RGEN 6389.28 286.00 6.13 278.40 8.11
Reata Pharmaceuticals, Inc. RETA 4824.84 20.00 22.85 -15.52 -150.30
Nektar Therapeutics NKTR 4363.04 137.00 3.41 -9.50 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 4053.40 1.00 37.48 -6.20 None
Allakos, Inc. ALLK 3236.42 None 7.03 -34.60 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2484.72 891.00 1.77 -8.50 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.72 None 6.80 -18.91 None
IGM Biosciences, Inc. IGMS 2237.27 None 9.86 -41.24 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1784.50 None 5.80 -28.62 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1578.64 30.00 5.62 -22.46 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1544.38 None 9.46 -16.76 None
Akcea Therapeutics, Inc. AKCA 1347.82 341.00 2.77 -47.91 -8.59
Tricida, Inc. TCDA 1319.57 None 6.78 -6.25 None
Kiniksa Pharmaceuticals Ltd. KNSA 1279.85 None 6.63 -10.58 None
Arcutis Biotherapeutics, Inc. ARQT 1154.40 None 4.92 -18.46 None
Akero Therapeutics, Inc. AKRO 1135.64 None 9.48 -22.38 None
Odonate Therapeutics, Inc. ODT 1127.52 None 9.24 -10.02 None
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Athenex, Inc. ATNX 1014.78 123.00 6.22 -9.43 -87.86
Constellation Pharmaceuticals, Inc. CNST 983.36 None 4.63 -10.60 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Gossamer Bio, Inc. GOSS 809.47 None 3.28 -4.07 None
Phathom Pharmaceuticals, Inc. PHAT 794.00 None 4.40 -2.92 None
Quanterix Corp. QTRX 732.51 60.00 6.46 -16.75 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Applied Therapeutics, Inc. APLT 711.70 14.00 4.60 -14.44 -19.41
Aprea Therapeutics, Inc. APRE 689.64 None 6.10 -20.40 None
Oric Pharmaceuticals, Inc. ORIC 687.96 None -7.47 -22.75 None
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Arcturus Therapeutics Holdings, Inc. ARCT 665.08 19.00 61.64 -23.91 -151.34
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 617.87 1679.00 4.25 -2.84 -11.85
Keros Therapeutics, Inc. KROS 612.72 8.00 -27.67 -28.85 -285.35
Oyster Point Pharma, Inc. OYST 548.10 None 5.51 -9.53 None
Mirum Pharmaceuticals, Inc. MIRM 486.50 None 3.16 -7.18 None
Fulcrum Therapeutics, Inc. FULC 476.10 1.00 8.02 -6.90 None
Biospecifics Technologies Corp. BSTC 462.28 40.00 3.75 19.77 61.80
SIGA Technologies, Inc. SIGA 460.84 19.00 5.16 -23.42 -94.00
89bio, Inc. ETNB 457.80 None 5.65 -7.09 None
Satsuma Pharmaceuticals, Inc. STSA 441.32 None 4.34 -12.13 None
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
DURECT Corp. DRRX 395.25 28.00 30.36 -16.35 -82.94
Relmada Therapeutics, Inc. RLMD 394.02 0.00 5.88 -32.92 -877.66
Kala Pharmaceuticals, Inc. KALA 383.04 6.00 4.19 -4.17 None
Crinetics Pharmaceuticals, Inc. CRNX 382.56 1.00 4.83 -6.56 -447.78
TCR2 Therapeutics, Inc. TCRR 368.64 None 2.52 -36.57 None
Ocular Therapeutix, Inc. OCUL 357.12 6.00 -43.76 -3.90 None
Ovid Therapeutics, Inc. OVID 344.25 None 8.14 -5.28 None
Osmotica Pharmaceuticals Plc OSMT 343.44 232.00 2.61 -1.25 -115.44
Aeglea Biotherapeutics, Inc. AGLE 303.27 4.00 9.57 -3.78 -523.27
Urovant Sciences Ltd. UROV 295.80 None -5.24 -2.05 None
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Spero Therapeutics, Inc. SPRO 268.28 12.00 3.53 -3.30 -656.72
AMAG Pharmaceuticals, Inc. AMAG 268.26 321.00 1.02 -0.72 -115.05
HOOKIPA Pharma, Inc. HOOK 267.80 13.00 2.42 -5.92 -333.02
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Lannett Co., Inc. LCI 242.82 542.00 0.83 -7.99 -5.77
Gritstone Oncology, Inc. GRTS 226.44 4.00 2.03 -2.17 None
KalVista Pharmaceuticals, Inc. KALV 211.68 12.00 2.34 -6.53 -263.38
Kaleido Biosciences, Inc. KLDO 207.90 None 7.37 -2.84 None
Veru, Inc. VERU 207.35 39.00 6.93 -21.27 -25.53
Sutro Biopharma, Inc. STRO 194.81 41.00 3.70 -3.20 -148.06
Protara Therapeutics, Inc. TARA 191.34 None 2.88 -12.41 None
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
LogicBio Therapeutics, Inc. LOGC 175.03 1.00 5.28 -4.11 None
Liquidia Technologies, Inc. LQDA 166.10 8.00 13.02 -3.37 -602.17
scPharmaceuticals, Inc. SCPH 156.37 119.00 4.00 -4.99 -27.05
Avenue Therapeutics, Inc. ATXI 156.00 532.00 28.68 -10.71 26.69
Cyclerion Therapeutics, Inc. CYCN 153.49 6.00 1.93 -1.48 None
Corvus Pharmaceuticals, Inc. CRVS 147.45 None 2.36 -3.12 None
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Lyra Therapeutics, Inc. LYRA 144.84 1.00 -1.23 -8.68 -491.16
Evelo Biosciences, Inc. EVLO 144.00 None 5.29 -1.64 None
PhaseBio Pharmaceuticals, Inc. PHAS 134.85 2.00 2.50 -2.82 None
Harrow Health, Inc. HROW 133.38 51.00 8.55 -5.40 -47.54
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 125.60 None 2.93 -2.55 None
TFF Pharmaceuticals, Inc. TFFP 117.80 None 4.56 -3.04 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
NeuBase Therapeutics, Inc. NBSE 117.04 None 49.18 -2.62 None
Ayala Pharmaceuticals, Inc. AYLA 115.41 3.00 -2.72 -5.59 -679.19
Evolus, Inc. EOLS 100.50 45.00 1.80 -0.99 -217.51
Trevi Therapeutics, Inc. TRVI 98.82 None 2.10 -3.37 None
Eton Pharmaceuticals, Inc. ETON 94.32 1.00 10.27 -4.72 None
Milestone Pharmaceuticals, Inc. MIST 93.86 None 0.93 -1.51 None
EyePoint Pharmaceuticals, Inc. EYPT 78.49 26.00 5.54 -1.60 -196.30
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Clearside Biomedical, Inc. CLSD 76.67 6.00 9.84 -4.35 -293.61
Xeris Pharmaceuticals, Inc. XERS 74.48 4.00 3.69 -0.57 None
Baudax Bio, Inc. BXRX 65.70 None -1.79 -0.94 None
Navidea Biopharmaceuticals, Inc. NAVB 64.60 1.00 -47.50 -5.85 -65.13
BiomX, Inc. PHGE 60.06 None 1.58 -1.40 None
Genprex, Inc. GNPX 59.60 None 5.06 -4.36 None
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aridis Pharmaceuticals, Inc. ARDS 55.44 1.00 -22.81 -1.90 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 53.71 20.00 1.62 -2.85 -51.58
Menlo Therapeutics, Inc. MNLO 49.30 2.00 4.15 -0.53 -483.51
Edesa Biotech, Inc. EDSA 45.36 0.00 6.46 -0.48 -395.23
Eyenovia, Inc. EYEN 44.20 None 4.46 -2.16 None
Annovis Bio, Inc. ANVS 42.49 None 3.89 -33.72 None
Moleculin Biotech, Inc. MBRX 40.94 None 3.56 -4.45 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Citius Pharmaceuticals, Inc. CTXR 35.37 None 2.62 -2.05 None
AgeX Therapeutics, Inc. AGE 33.82 2.00 -44.50 -2.78 -658.11
Allena Pharmaceuticals, Inc. ALNA 33.81 None 4.45 -0.78 None
Mannatech, Inc. MTEX 33.70 156.00 1.42 7.59 3.45
Oncternal Therapeutics, Inc. ONCT 33.67 3.00 4.32 -1.34 -225.89
Acer Therapeutics, Inc. ACER 32.20 3.00 2.35 -1.23 -274.69
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Aileron Therapeutics, Inc. ALRN 30.80 None 4.23 -1.16 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Millendo Therapeutics, Inc. MLND 25.20 0.00 0.59 -0.54 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.77 0.00 0.94 -0.95 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Adial Pharmaceuticals, Inc. ADIL 15.00 None 3.66 -1.97 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.33 5.00 -3.29 -0.45 -602.34
PDS Biotechnology Corp. PDSB 13.30 None 1.47 -0.52 None
Titan Pharmaceuticals, Inc. TTNP 12.07 4.00 5.03 -0.67 -437.91
Novus Therapeutics, Inc. NVUS 7.44 None 0.64 -0.35 None
Brickell Biotech, Inc. BBI 4.68 5.00 1.53 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

PDS Biotechnology Corp.

10d ago, source: MarketWatch

Frank K. Bedu-Addo is an entrepreneur who founded PDS Biotechnology Corp., PDS Operating Corp. and KBI Biopharma, Inc. Currently, he is President, CEO, Chief Financial Officer & Director at PDS ...

Why Developments for Targeted Therapies Are Expected to Drive Sales for Brain Tumor Drug Market

1d ago, source: MarketWatch

The brain tumor drugs market consist of sales of drugs which are used to cure a mass growth of abnormal cells in the human brain. These drugs are either used alone or in combinations, depending on the ...

BRIEF-PDS Biotechnology And Farmacore Biotechnology To Co-Develop PDS0204 Covid-19 Vaccine

22d ago, source: Reuters

PDS BIOTECHNOLOGY CORP - CO, FARMACORE WILL ACCELERATE DEVELOPMENT OF VERSAMUNE COV-2FC INTO PHASE 1 CLINICAL TESTING IN BRAZIL * PDS BIOTECHNOLOGY CORP - FARMACORE RETAINS COMMERCIALIZATION ...

65 Biggest Movers From Yesterday

8d ago, source: MSN

PDS Biotechnology Corporation (NASDAQ: PDSB) declined 22.7% to close at $2.01 after climbing more than 60% on Monday. Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) dropped 21.8% to close at $11.01 after ...

FDA Snubs HRTX Again, ICPT Disappoints, KNSA Hits Right Notes, Is The Writing On The Wall For VRCA?

9d ago, source: Nasdaq

In its Complete Response Letter, the FDA has cited four non-clinical issues as the reasons for denying approval to HTX-011.

PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine

22d ago, source: YAHOO!

PDS Biotechnology Corporation (PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune ® T ...

PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine

22d ago, source: Nasdaq

FLORHAM PARK, N.J., June 17, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.